Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Total Current Liabilities (2020 - 2026)

Global Innovative Platforms' (GIPL) quarterly Total Current Liabilities came in at $7791.0 in Q2 2026, down 72.0% year-over-year from $27823.0 in Q2 2025, and up 241.11% quarter-over-quarter from $2284.0 in Q1 2026.

Analysis

Global Innovative Platforms (GIPL) Total Current Liabilities (2020 - 2026) Analysis & Trends

Global Innovative Platforms has disclosed Total Current Liabilities across 7 years of filings, most recently posting $7791.0 for Q2 2026.

  • In Q2 2026, Total Current Liabilities fell 72.0% year-over-year to $7791.0; the TTM figure through Jun 2026 stood at $7791.0 (down 72.0% YoY), while the FY2025 annual figure was $11609.0, down 64.98% from the prior year.
  • Total Current Liabilities came in at $7791.0 for Q2 2026 at Global Innovative Platforms, up from $2284.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $364368.0 in Q3 2023 to a low of $2284.0 in Q1 2026.
  • Average Total Current Liabilities over 5 years is $115716.8, with a median of $56578.0 recorded in 2022.
  • Year-over-year, Total Current Liabilities jumped 556.62% in 2022 and sank 98.39% in 2025.
  • Over 5 years, Total Current Liabilities stood at $234283.0 in 2022, then slipped by 15.4% to $198200.0 in 2023, then slumped by 92.73% to $14407.0 in 2024, then surged by 356.61% to $65784.0 in 2025, then plunged by 88.16% to $7791.0 in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $7791.0 in Q2 2026, $2284.0 in Q1 2026, and $65784.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Idexx Laboratories 40.31 Bn 40.11 Bn 779.09 Mn 1.29 Bn
2 Zoetis 30.55 Bn 28.87 Bn 1.05 Bn 2.06 Bn
3 Elanco Animal Health 11.57 Bn 11.04 Bn 798.00 Mn 1.85 Bn
4 Phibro Animal Health 1.49 Bn 1.40 Bn 134.40 Mn 316.47 Mn
5 Immucell 89.38 Mn 80.52 Mn 2.44 Mn 4.44 Mn
6 Zhengye Biotechnology Holding 76.69 Mn 69.60 Mn - 16.99 Mn
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - 7,791.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,791.00
Mar 31, 2026 2,284.00
Dec 31, 2025 65,784.00
Sep 30, 2025 11,609.00
Jun 30, 2025 27,823.00
Mar 31, 2025 3,229.00
Dec 31, 2024 14,407.00
Sep 30, 2024 33,153.00
Jun 30, 2024 216,897.00
Mar 31, 2024 200,997.00
Dec 31, 2023 198,200.00
Sep 30, 2023 364,368.00
Jun 30, 2023 241,761.00
Mar 31, 2023 241,711.00
Dec 31, 2022 234,283.00
Sep 30, 2022 130,471.00
Jun 30, 2022 47,372.00
Mar 31, 2022 40,763.00
Dec 31, 2021 35,680.00
Sep 30, 2021 29,160.00